An. R. Acad. Farm. vol 79 nº 1 2013 - page 150

J. R. Lacadena y F. Mayor Menéndez
150
28. Kobilka, B. K.; Kobilka, T. S. et al. Chimeric alpha 2-­‐,beta 2-­‐adrenergic receptors: delineation
of domains involved in effector coupling and ligand binding specificity. Science 240, 1310-­‐
1316 (1988).
29. Pitcher, J.A; Freedman, N.J.; Lefkowitz, R.J. G protein-­‐coupled receptor kinases. Annu Rev
Biochem 67, 653-­‐792 (1998).
30. Lefkowitz ,R.J.; Shenoy, S.K. Transduction of receptor signals by beta-­‐arrestins. Science
308, 512-­‐517 (2005)
31. Rasmussen, S. G.; Choi, H. J. et al. Crystal structure of the human beta2 adrenergic G-­‐
protein-­‐coupled receptor. Nature 450, 383-­‐387 (2007).
32. Cherezov, V.; Rosenbaum, D. M. et al. High-­‐resolution crystal structure of an engineered
human beta2-­‐adrenergic G protein-­‐coupled receptor. Science 318, 1258-­‐1265 (2007).
33. Rosenbaum, D. M.; Cherezov, V. et al. GPCR engineering yields high-­‐resolution structural
insights into beta2-­‐adrenergic receptor function. Science 318, 1266-­‐1273 (2007).
34. Palczewski, K.; Kumasaka, T. et al. Crystal structure of rhodopsin: A G protein-­‐coupled
receptor. Science 289, 739-­‐745 (2000).
35. Okada, T.; Fujiyoshi, Y. et al. Functional role of internal water molecules in rhodopsin
revealed by X-­‐ray crystallography. Proc Natl Acad Sci USA 99, 5982-­‐5987. (2002).
36. Katritch, V.; Cherezov, V. et al. Structure-­‐function of the g protein-­‐coupled receptor
superfamily. Annu Rev Pharmacol Toxicol 53, 531-­‐556 (2013).
37. Katritch, V.; Cherezov, V. et al. Diversity and modularity of G protein-­‐coupled receptor
structures. Trends Pharmacol Sci 33, 17-­‐27 (2012).
38. Rasmussen, S.G.; DeVree, B.T. et al. Crystal structure of the beta2 adrenergic receptor-­‐Gs
protein complex. Nature 477, 549-­‐555 (2011).
39. Chung, K. Y.; Rasmussen, S. G. et al. Conformational changes in the G protein Gs induced by
the beta2 adrenergic receptor. Nature 477, 611-­‐615 (2011).
40. Penela, P., Murga, C. et al. The complex G protein-­‐coupled receptor kinase 2 (GRK2)
interactome unveils new physiopathological targets. Br J Pharmacol 160, 821-­‐832 (2010).
1...,140,141,142,143,144,145,146,147,148,149 151,152,153,154,155,156,157,158,159,160,...172
Powered by FlippingBook